Cel-Sci Email Format
Biotechnology Research11-50 Employees
Cel-Sci is a biotechnology research company based in Vienna, Virginia. The organization operates with a small-to-mid-sized team and concentrates on developing and potentially bringing to market its immunotherapy candidate Multikine. In 2026, Cel-Sci announced a strategic agreement with Amarox to register, commercialize, and distribute Multikine in Saudi Arabia. This partnership illustrates the company's ongoing efforts to advance regional commercialization of its product within the biotechnology sector.